Gagan Gases (524624)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Positive book value of ₹7.15 per share provides some asset cushion even when earnings are weak.
• ROCE of 10.64% shows the operating assets can generate a double-digit pre-tax return before leverage effects.
• Industrial gases are essential, repeat-use inputs for manufacturing, giving the industry a natural recurring-demand characteristic.
• With a ₹10 Cr market cap, a small absolute increase in profitability could have an outsized per-share impact.

Concerns

• Trading at 83.45 times trailing earnings while sales and profit are shrinking by 8.06% and 11.11% respectively.
• Latest quarter sales of ₹2 Cr and net profit of ₹0 Cr suggest the company is barely breaking even.
• ROE of 3.80% and a Piotroski F-Score of 3/9 point to weak profitability and poor financial health.
• No dividend and undisclosed promoter/debt details leave little margin of safety for a minority investor.

AI Analysis

Let me start with a confession: this is exactly the kind of stock I usually avoid. Gagan Gases operates in industrial gases, a business I can understand—gases are consumables for industry. But understanding the product is not the same as understanding the economics. Sales fell 8.06%, profits fell 11.11%, and the latest quarter shows revenue of just ₹2 Cr with net profit of ₹0 Cr. That is not a business compounding; it is a business stalling. The financial health also fails my inspection. Return on equity is only 3.80%, the Piotroski F-Score is a weak 3/9, and there is no dividend. I cannot even evaluate the balance sheet properly because debt/equity and promoter holding are not available. As Graham said, the market is not a voting machine but a weighing machine; today the scale shows a company earning almost nothing. The price of ₹22.11 translates to a P/E of 83.45 and a price-to-book of 3.09 against a book value of ₹7.15. Paying over 80 times earnings for declining profits is the opposite of a margin of safety. Even the 52-week range of ₹11.90-₹37.69 shows a speculative microcap, not a stable business. Yes, ROCE of 10.64% suggests the core assets are not worthless, and a tiny ₹10 Cr market cap means a small absolute recovery could move per-share numbers. But I do not invest in hopes; I invest in evidence. Until I see quarterly sales improving, net profit consistently above zero, higher ROE, and better disclosures, this is a possible turnaround at best—and most turnarounds do not turn. I would rather miss this move than risk my capital on an unproven situation.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer